NES Involves Measurable Phase Delays in 5 Circadian Hormones, Altered HPA Axis Activity, and Disrupted Peripheral Clock Gene Expression — This Is Biology, Not Choice
Night Eating Syndrome (NES) was formally recognized as a clinical entity in 1955 by Dr. Albert Stunkard, and in 2013 it was included in the DSM-5 under 'Other Specified Feeding or Eating Disorder.' Despite this clinical recognition, NES remains profoundly underdiagnosed — most women with NES have never heard the term and believe their nighttime eating reflects personal weakness rather than a diagnosable circadian metabolism disorder. The diagnostic criteria require two of three features: evening hyperphagia (consuming 25%+ of daily calories after the evening meal), nocturnal ingestions (waking from sleep to eat at least twice per week), and morning anorexia (lack of appetite in the morning). NES affects 1.5% of the general population but up to 8-15% of women seeking treatment for obesity, suggesting that it is a significant unrecognized driver of weight gain. The biological basis of NES has been established through comprehensive hormonal profiling: NES patients show phase delays in five circadian hormones — leptin (delayed 1.0-2.8 hours), insulin (delayed 1-2 hours), melatonin (delayed 1-1.5 hours), and cortisol rhythm alterations (blunted morning peak, elevated nocturnal levels) — and a dramatic phase advance in ghrelin (5.2 hours). These are not voluntary behavioral patterns — they are measurable circadian hormone disruptions that produce the eating behavior as their downstream consequence.[1]
The neuroendocrine architecture of NES involves disrupted communication between the central circadian clock and the peripheral metabolic clocks that govern eating behavior. The SCN master clock sends timing signals to the rest of the body through cortisol, melatonin, autonomic nervous system activity, and core body temperature rhythms. In NES, these output signals are altered: the cortisol awakening response is blunted (reducing morning appetite and energy), nocturnal cortisol is elevated (promoting evening hunger), and the melatonin onset is slightly delayed (pushing the sleep-preparation window later). These central clock alterations desynchronize the peripheral clocks in the liver, pancreas, and adipose tissue — which rely on feeding time as their primary zeitgeber — creating a cascade of metabolic dysfunction. The liver's circadian clock governs the timing of glucose production, lipid metabolism, and bile acid synthesis; when food consistently arrives during the liver's 'rest phase,' hepatic clock gene expression (BMAL1, CLOCK, PER, CRY) becomes desynchronized from the SCN, producing metabolic inflexibility — the liver cannot efficiently switch between fed-state and fasted-state metabolism. This metabolic inflexibility manifests as both fasting hyperglycemia (the liver produces glucose when it shouldn't) and postprandial hyperlipidemia (the liver stores fat from late meals inefficiently, leading to elevated circulating triglycerides).
Research shows the gender disparity in NES — which affects women more frequently and with greater metabolic severity than men — is rooted in the serotonin system's central role in both circadian eating patterns and female neurobiology. NES is fundamentally a serotonin-related disorder: the most effective pharmacological treatment is sertraline (an SSRI), and tryptophan depletion studies show that reducing serotonin availability acutely worsens NES symptoms. Serotonin modulates the SCN's output to feeding-related hypothalamic nuclei, and when serotonin is deficient, the circadian signal that suppresses nighttime appetite is weakened. Women's 52% lower serotonin synthesis rate (Nishizawa et al.) creates a lower baseline from which the circadian serotonin decline operates, making them more likely to reach the 'appetite brake failure' threshold in the evening. The menstrual cycle adds monthly vulnerability: during the late luteal phase, declining estrogen reduces serotonin receptor sensitivity, and progesterone's appetite-stimulating effects compound the serotonin-mediated appetite brake failure. Women with NES report consistent premenstrual worsening of nighttime eating, with binge-level episodes more common in the week before menstruation. The perimenopause transition often marks a dramatic worsening of NES: as baseline estrogen declines permanently, serotonergic tone drops chronically, and the circadian eating disruption that was previously confined to the luteal phase becomes a persistent daily pattern.
Managing NES as a circadian metabolism disorder requires restoring the circadian hormone rhythms and serotonergic function that the syndrome disrupts — behavioral interventions alone (such as 'don't eat after dinner') fail because they address the downstream behavior rather than the upstream hormonal disruption driving it. Tulsi (Holy Basil) addresses the cortisol rhythm abnormality that is central to NES — the elevated nocturnal cortisol and blunted morning cortisol response. By normalizing HPA axis function, Tulsi helps restore the cortisol rhythm that serves as a zeitgeber for peripheral metabolic clocks, supporting their resynchronization with the central clock. Tulsi's anxiolytic properties also reduce the stress-HPA axis activation that perpetuates the cortisol rhythm disruption. Green Tea EGCG provides the serotonergic support that NES specifically requires: L-theanine directly increases brain serotonin levels, strengthening the circadian appetite suppression signal that NES weakens; and EGCG's thermogenic activation compensates for the metabolic rate reduction that the nocturnal eating pattern produces. EGCG has also been shown to modulate circadian clock gene expression (BMAL1, PER2) in peripheral tissues, potentially supporting the resynchronization of liver and adipose clocks that NES desynchronizes. Oleuropein targets the systemic inflammation that circadian disruption produces — chronic inflammation impairs hypothalamic clock function and worsens the desynchronization that drives NES. Oleuropein's hepatoprotective properties also support liver clock function, addressing the metabolic inflexibility that desynchronized hepatic clocks create. Cayenne capsaicin provides TRPV1-mediated appetite suppression that operates independently of circadian timing, offering a reliable satiety signal during the evening hours when NES's circadian signals are disordered. African Mango restores leptin rhythm amplitude, helping the phase-delayed leptin signal produce its satiety effect more strongly when it does arrive. The liquid formulation delivers these circadian-support compounds in a format designed for daytime consumption, reinforcing the healthy feeding-time signal that helps re-entrain peripheral metabolic clocks.
People with obesity consistently have less Turicibacter. The microbe may promote healthy weight in humans.
— Dr. June Round, University of Utah, 2025
What This Means For You
The data is published. The mechanism is confirmed. The compounds exist.
The only variable is whether you act on the science — or wait for your doctor to hear about it in 2042.